Saturday, October 10, 2026

Back to today

From X

@StableBread

Fajasy on X

The ransomware software of Nubeva Technologies $NBVAF (TSXV: $NBVA) passed every test in a month-long third-party lab evaluation in 2023, and its biggest customer, Kroll, walked away anyway. In January 2022, Nubeva launched Ransomware Reversal, or NuRR, the product the company is now built around. It’s a lightweight agent installed on servers, desktops, and laptops that watches for the file encryption a ransomware attack produces, captures copies of the encryption keys as the malware generates them, and stores those keys on the customer’s own network. After the attack, Nubeva uses the captured keys to build a decryptor (a program that reverses the encryption) and hands the customer its data back, without the ransom. The only outside test of NuRR I found was a month-long evaluation in 2023 at DreamPort, a lab in Maryland (the test doesn’t appear to have been commissioned by Nubeva). DreamPort is run by the Maryland Innovation and Security Institute (MISI), a nonprofit that partners with U.S. Cyber Command to connect the military with outside cybersecurity products. Per Nubeva’s July 20, 2023 release, NuRR passed all 17 tests in MISI’s test plan and captured the encryption keys in every attack, including ones using the LockBit, Ragnar Locker, and BlackBasta ransomware strains. But less than two months after the MISI results, Nubeva lost its biggest customer: → January 2023: Nubeva named Kroll, the risk advisory firm that runs more than 3,000 incident-response investigations a year, as a strategic partner using the product in its ransomware cases. → September 2023: Kroll ended the relationship and paid $180,000 to walk away. It had been 86% of FY2023 revenue (~$1.78M of $2.07M). Neither company gave a reason in a filing or press release. But in a July 2024 video on Nubeva’s YouTube channel, CEO Randy Chou said Kroll sometimes brought in 10 ransomware cases on the same weekend, and “neither the partner or us as a complete solution could handle the emergency services.” In an October 2025 video, he explained the constraint further. Each new ransomware variant needs its own decryptor, which Nubeva’s engineers built by hand. With 10 to 30 attacks running at once, “you don’t have enough engineers to go figure out the new decryptor.” Chou added that Nubeva “simply cannot afford to scale” its support, “and that’s still the reality,” so it’s waiting on automation before it grows again. A longtime investor I spoke with, who has followed Nubeva for years and has spoken with people who’ve used NuRR in the field, described the same constraint. He also says Kroll’s exit is why Nubeva stopped trying to grow on its own and bet on AI to write the decryptors.

TSOH Weekly Roundup (10/09/2026)

Paramount Skydance’s debt-heavy Warner Bros. Discovery acquisition, streaming bundle pricing and alcohol-industry diversification anchor…

Boyz in the Hood

Robinhood’s AI agents, 24/7 equity trading and 10:1 crypto perpetual futures encourage higher retail trading velocity, leverage and…

Namib Minerals: Research Note

Namib Minerals posted H1 adjusted EBITDA of $19.0 million, up 76%, as higher gold prices offset lower production.

BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

Golar LNG q2’26 Operational Update

Golar LNG ordered a $2.45 billion fourth FLNG vessel, targeting 3.5MTPA of capacity and $400 million in annual EBITDA under a 20-year…

Top Rebound Stocks for Oct’26

Intuitive Surgical, down 32% from its January 2025 peak, faces slower US procedure growth and new robotic-surgery rivals despite $10.1…

Publications we follow

Every publication on this site, hand-picked.

109 publications

Newsletters 92

X accounts we follow

Every account on this site, hand-picked.

74 accounts

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.